A detailed history of Congress Asset Management CO transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Congress Asset Management CO holds 209,070 shares of TNGX stock, worth $677,386. This represents 0.01% of its overall portfolio holdings.

Number of Shares
209,070
Previous 211,170 0.99%
Holding current value
$677,386
Previous $1.81 Million 11.15%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$7.36 - $11.93 $15,456 - $25,053
-2,100 Reduced 0.99%
209,070 $1.61 Million
Q2 2024

Aug 02, 2024

BUY
$6.66 - $10.15 $1.41 Million - $2.14 Million
211,170 New
211,170 $1.81 Million

Others Institutions Holding TNGX

About Tango Therapeutics, Inc.


  • Ticker TNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,067,296
  • Market Cap $285M
  • Description
  • Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...
More about TNGX
Track This Portfolio

Track Congress Asset Management CO Portfolio

Follow Congress Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Congress Asset Management CO with notifications on news.